Reporting to the Production and Quality Manager you will work in the production and formulation of chemicals to support trials and commercial orders. We may also offer the opportunity for longer internships. You will have a rare opportunity to learn first hand how a start up company scales up it’s production to meet new customer demands.
I hope we have a lot more than 2 million don’t forget we are going to hand out cash bonuses !!!!!!! mark gets £270,000 and Jeremy would get a cash bonus of £180,000 once they complete a significant acquisition.
Melissa Ward Sales Director Pharm2Farm has a proven record of end-to-end deal closures in medical sales. Melissa’s initiative-and forward thinking combined with excellent presentation skills supports impressive levels of communication.
Melissa has knowledge of the current PPE sales compliance and technologies which is key to generating and leading sales for large global accounts and engaging customers in negotiation of complex, bespoke contracts, and pricing models.
Melissa has a BSc (Hons) in Chemistry and has previously been responsible for sales accounts worth more than 3 million pounds in revenue. Her strong people skills encourage team cooperation and motivate strategic thinking.
The first address that mark set the company up at looks to me to be his home address . He just told everyone where he lives . What I would say is what was the rush ?
GBNano ltd Company number: 13987504 Incorporation year: 2022 Legal structure: Private Limited Company status: active Number of employees: - Industry sector: MANUFACTURE OTHER INORGANIC BASIC CHEMICALS Phone number: - General Financial DIRECTORS AND FILINGS Current Directors: 1 Previous Directors: 0 DUFFIN, Mark ( 1967-05 ) | director | 1967-05-01 | N/A )
“ Become a Virosynth Technology and Additive Supplier”
Not seen this on the website before , I’m now hoping the machines have been Converted and we are ready for orders …….. just need to plug the phones in now :)
As an example, pioneering Nano Technology initially developed for the medical industry has been optimised for plant and animal nutrition. Several trials have shown increased nutritional content through fortification, shelf-life, increased nutrient use and a lower environmental footprint. The technology has moved from the laboratory to full production. Ground-breaking trials has shown interest from several growers and processors. This pioneering technology was initially developed to enrich the nutritional value of potatoes, in conjunction with the Agriculture and Horticulture Development Board (AHDB” which represents farmers.